Valley National Advisers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5
| Closed | -$1K | – | 1119 |
|
|
2023
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 936 |
|
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 970 |
|
|
2022
Q4 | $0 | Sell |
5
-1,399
| -100% | – | ﹤0.01% | 973 |
|
|
2022
Q3 | $18K | Hold |
1,404
| – | – | ﹤0.01% | 513 |
|
|
2022
Q2 | $20K | Buy |
1,404
+1,399
| +27,980% | +$19.9K | ﹤0.01% | 486 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 982 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 962 |
|
|
2021
Q3 | $0 | Sell |
5
-55
| -92% | – | ﹤0.01% | 936 |
|
|
2021
Q2 | $1K | Hold |
60
| – | – | ﹤0.01% | 851 |
|
|
2021
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 816 |
|
|
2020
Q4 | $1K | Hold |
60
| – | – | ﹤0.01% | 773 |
|
|
2020
Q3 | $1K | Hold |
60
| – | – | ﹤0.01% | 742 |
|
|
2020
Q2 | $1K | Hold |
60
| – | – | ﹤0.01% | 745 |
|
|
2020
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 727 |
|
|
2019
Q4 | $1K | Hold |
60
| – | – | ﹤0.01% | 730 |
|
|
2019
Q3 | $1K | Hold |
60
| – | – | ﹤0.01% | 735 |
|
|
2019
Q2 | $1K | Hold |
60
| – | – | ﹤0.01% | 705 |
|
|
2019
Q1 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 704 |
|